Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer after FOLFIRINOX chemotherapy
Background: To evaluate the efficacy and optimal timing of local treatment in patients with borderline resectable (BR) or locally advanced pancreatic cancer (LAPC) treated with upfront FOLFIRINOX. Method: Between 2015 and 2020, 258 patients with pancreatic ductal adenocarcinoma (PDAC) were analysed....
Những tác giả chính: | , , , , , , , , , , , , , |
---|---|
Định dạng: | Bài viết |
Ngôn ngữ: | English |
Được phát hành: |
Elsevier
2024-03-01
|
Loạt: | Clinical and Translational Radiation Oncology |
Những chủ đề: | |
Truy cập trực tuyến: | http://www.sciencedirect.com/science/article/pii/S2405630824000090 |